Clinical Trial Update: Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) [Phase 3]

View source ↗

Summary

Phase 3 LIFE study update on losartan intervention for hypertension and left ventricular hypertrophy; completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart) | Phase 3 | Status: COMPLETED